Not with certainty, but from memory I think Teva deal was...

First 21 Last

Share
Profile

Follow
Patrick31

1,519 Posts.

269

20/04/25

11:52

Post #: 78747217
Share

Originally posted by Hiddenvalue: ↑

Agree, our previous board approved purchase of TEVA at multiples of expected/ projected earnings. Nothing wrong with this, as this is the industry norm in valuations.

Our current board should have been consistent and expected a scheme offer at multiples of ACTUAL current EARNINGS at minimum which I cannot see has been achieved with the offer price.

Waiting to see how this offer has been in our best interest to accept with earnings and profitability to grow. The purchasers payback will be possibly 1 X EBITDA, certainly less than 2 X EBITDA which is an absolute bargain in any industry metric. What listed company on the crusp of profitable operations sells for 1 X, let alone 2 X earnings???? I would like a specific example in pharma provided by the IE if a statement is made it is fair.

We have spent our $$$$, not the boards $$$$ on projected earnings in the past and yet have not achieved with this specific offer a multiple of current actual earnings,. This is my biggest question on the proposed transaction that's needs clarification and justification.

I would like more of an explanation and commentary to shareholders in relation to this rather than a fluffy statement.

Imagine how you would feel as a vendor if you knew your neighbours in Bondi were getting millions for their properties but your agent has told you to consider accepting an offer at a fraction of that price because it would be beneficial to bring a new face into the neighbourhood and make the new purchaser very happy. In fact the purchaser may eventually flip the property for some extra $$$$ because they know that with a little patience they can make some real $$$#$.

How does that make you feel??

Expand

Not with certainty, but from memory I
think Teva deal was multiple of 6.

MYX Price at posting: $7.05 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

AVM

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

STO

Santos jumps +15% as ADNOC takeover deal digested

THL

Today's top gainer stock isn't an energy player. Here's what's going on

4DS

4DS Memory tanks as microchip tech tests fail to produce result

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

First 21 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.02		Change -0.180(3.46%)		Mkt cap ! $406.2M

Open	High	Low	Value	Volume
$5.19	$5.19	$4.97	$396.8K	78.66K

Buyers (Bids)

No.	Vol.	Price($)
6	1462	$5.01

Sellers (Offers)

Price($)	Vol.	No.
$5.02	409	3

View Market Depth

No.	Vol.	Price($)
1	141	5.010
1	502	4.990
2	671	4.980
3	577	4.970
2	1457	4.960

Price($)	Vol.	No.
5.020	89	1
5.030	4508	3
5.040	225	1
5.050	225	1
5.060	321	2

Last trade - 11.51am 16/06/2025 (20 minute delay)

MYX (ASX) Chart

Not with certainty, but from memory I think Teva deal was...

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

Santos jumps +15% as ADNOC takeover deal digested

Today's top gainer stock isn't an energy player. Here's what's going on

4DS Memory tanks as microchip tech tests fail to produce result

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Not with certainty, but from memory I think Teva deal was...

Top Stories

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

Santos jumps +15% as ADNOC takeover deal digested

Today's top gainer stock isn't an energy player. Here's what's going on

4DS Memory tanks as microchip tech tests fail to produce result

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News